Skip to main content
. 2016 Dec 15;8(2):155–160. doi: 10.1111/jdi.12593

Figure 1.

Figure 1

Lipid‐lowering effects of dipeptidyl peptidase‐4 inhibitors in low‐density lipoprotein receptor‐deficient mice with anagliptin (Ana). (a) Bodyweight (BW). Plasma concentrations of (b) total cholesterol (TC) and (c) triglyceride (TG) after 4 weeks of treatment. Data are shown as mean ± standard error of the mean (n = 10). **P < 0.01.